IJPRS

Home Abstract

Preparation and Evaluation Glutaraldehyde Cross Linked Chitosan Microspheres Containing Rivastigmine Tartrate


Received On: 04/06/2012
Accepted On: 11/06/2012


Author(s)

Panchal, A.M., Patel, K.S., Patel, M.B., Oza, P.J., Jobanputra, U.M., Meghnathi, U.R.


Author's Affiliation


Abstract

Rivastigmine tartrate is an anticholine esterase inhibitor that used in the treatment of Alzheimer's disease. In this study an attempt was made to encapsulate the Rivastigmine tartrate in Chitosan microspheres for controlled delivery of it. Chitosan microspheres were prepared by the emulsion cross linking method were Glutaraldehyde saturated toluene (GST) was used as a cross linker. Total four batches were prepared with different amount of Glutaraldehyde. It was found that GST had no significant effect on % yield, also increase in amount of GST decrease the particle size and increases the entrapment. GST had shown significant effect on the in vitro drug release and found that increase in amount of GST prolongs the drug release from 36 to 96 hrs. Chitosan microspheres shown to be follow the Higuchi model.


Keywords

Rivastigmine tartrate, Chitosan, microspheres, Glutaraldehyde

Cite This Article

Panchal, A.M., Patel, K.S., Patel, M.B., Oza, P.J., Jobanputra, U.M., Meghnathi, U.R. (2012). Preparation and Evaluation Glutaraldehyde Cross Linked Chitosan Microspheres Containing Rivastigmine Tartrate, International Journal for Pharmaceutical Research Scholars (IJPRS), 1(2), 206-213 .


Recent Articles

Get FREE Updates for Upcoming
Pharma News, Jobs & Conferences

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

IJPRS will use the information you provide on this form to be in touch with you and to provide updates and marketing.